An in-depth look to CMG PHARMACEUTICAL CO., LTD. operating, investing, and financing activities

058820 free cash flow for Q3 24 is -1.73 B KRW. For 2023, 058820 free cash flow was -8.45 B KRW and operating cash flow was 3.94 B KRW.